Cannabis is becoming mainstream - you can pick up CBD oil at your local Boots - what the hell is going on!?! As the cannabis industry in Canada and parts of the US is starting to grab headlines, medicinal cannabis in Europe is starting to gain traction as well. Experts predict the worldwide industry could be worth in excess of $300bn within 10 years, with Europe forming the biggest market within that, so there's plenty to get excited about.
I want to find out more about what's happening, and I'm bringing you along for the ride. Join me as I speak to a wide variety of guests who are helping to shape this nascent sector. I'll be interviewing patients, lawyers, doctors, scientists, entrepreneurs, investors and many more, as we discover how, and why, this much maligned and misunderstood plant is giving birth to a huge global business.
EPISODE #80 Interviewing the Godfather of Cannabis Research - Prof. Raphael Mechoulam
In this very special episode of The Cannabis Conversation, we explore the history of cannabis research, alongside taking a detailed look at the function and physiology of the endocannabinoid system.
EPISODE #79 Investigating CBN with Alan Ridgeway, Co-Founder and CEO at FloraWorks
Exploring one of the 'minor' cannabinoids - CBN. We take a look at its incredible therapeutic properties, mechanism of action, and its potential as a market disruptor.
EPISODE #78 Cannabis and Cosmetics with Leah Fletcher, CEO at Arbutus Health Group
Exploring the benefits and applications of using cannabis topically, looking into how cosmetics are formulated, regulatory concerns, and the future use of CBD within cosmetics.
EPISODE #77 Medical Cannabis Regulation with Benedikt and Jakob Sons, Co-founders at Cansativa
This week, we take a detailed look into the current medical cannabis regulations in Germany, including the differences between federal and state governance, cannabis’ status as both a medical product and narcotic, and we share some thoughts on how this sector should be regulated going forward.
EPISODE #76 Standardisation and Medical Cannabis with Oliver Zugel, CEO at Foliumed
We explore standardisation of cannabis as a medical product, including Good Manufacturing Practices (GMP), the challenges of standardising flower, and the market trend towards using extracts within medical applications.
EPISODE #75 Cannabis 2.0 in Canada with Tyler Robson, CEO at The Valens Company
Together, we discuss the newest wave of cannabis legalisation and innovation in Canada - Cannabis 2.0. We explore novel extraction techniques, the power of extracts and derivatives, the newest products on the market, and opportunities for the future.